Autologous haematopoietic stem cell transplantation for aggressive multiple sclerosis: the Swedish experience
Background Autologous haematopoietic stem cell transplantation (HSCT) is a viable option for treatment of aggressive multiple sclerosis (MS). No randomised controlled trial has been performed, and thus, experiences from systematic…